We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Parliament has passed legislation to replace the existing Research and Development (R&D) tax concession with a simplified R&D tax incentive (also known as the R&D tax offsets
An application to declare invalid the placement of two cholesterol lowering drugs in the same therapeutic group was recently rejected by the Federal Court
Some recent changes to anti-bribery and corruption laws in a number of jurisdictions, together with current high levels of regulator activity, have increased the compliance risks for both companies and individuals
